rescription and non-prescription medicines, vitamins and herbal supplements. Some medicines may affect how ZOLINZA works, or ZOLINZA may affect how your other medicines work. Especially tell your doctor if you take:
Know the medicines you take. Keep a list of your medicines and show it to your doctor and pharmacist when you get a new medicine.
How should I take ZOLINZA?
What are the possible side effects of ZOLINZA?
ZOLINZA may cause serious side effects . Tell your doctor right away if you have any of the following symptoms:
In addition, the most common side effects with ZOLINZA include:
Tell your doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of ZOLINZA. For more information, ask your doctor or pharmacist.
General information about ZOLINZA
Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use ZOLINZA for a condition for which it was not prescribed. Do not give ZOLINZA to other people, even if they have the same symptoms you have. It may harm them.
Keep ZOLINZA and all medicines out of the reach of children .
This leaflet summarizes the most important information about ZOLINZA. If you would like to know more information, talk to your doctor. You can ask your doctor or pharmacist for information about ZOLINZA that is written for health professionals.
What are the ingredients in ZOLINZA?
Active ingredient : vorinostat
Inactive ingredients : microcrystalline cellulose, sodium croscarmellose and magnesium stearate. The inactive ingredients in the capsule shell are titanium dioxide, gelatin, and sodium lauryl sulfate.
How should I store ZOLINZA?
Store ZOLINZA at room temperature, 68°F to 77°F (20°C to 25°C).
Merck Sharp & Dohme Corp., a subsidiary of MERCK & CO., INC. Whitehouse Station, NJ 08889, USA
Issued: October 2010
9762604
Copyright © 2006, 2009 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved
This is a representative sample of the packaging. Please see How Supplied section for a complete list of available packaging.
PRINCIPAL DISPLAY PANEL - Bottle Label 100 mg
Zolinza (vorinostat) capsules
Each capsule contains 100 mg vorinostat.
Rx only
120 Capsules
100mg
NDC 0006-0568-40
Store at 20-25°C (68-77°F), excursions permitted between 15-30°C (59-86°F). [See USP Controlled Room Temperature.]
USUAL ADULT DOSAGE: See accompanying circular.
Direct contact of the powder in ZOLINZA capsules with the skin or mucous membranes should be avoided. (See accompanying circular.)
Manuf. for: Merck Sharp & Dohme Corp., a subsidiary ofMERCK & CO., INC.Whitehouse Station, NJ 08889, USA
Manuf. by:Patheon, Inc.Mississauga, Ontario, Canada L5N 7K9
Formulated in Canada
9723103120 | No. 3883
Manufacturer
Merck Sharp & Dohme Corp.
Active Ingredients
Source
U.S. National Library of Medicine
DailyMed
Last Updated: 2nd of March 2011
